Literature DB >> 20332230

FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.

Bingbing Dai1, Russell O Pieper, Dawei Li, Ping Wei, Mingguang Liu, Shiao Y Woo, Kenneth D Aldape, Raymond Sawaya, Keping Xie, Suyun Huang.   

Abstract

Our recent studies have shown that the FoxM1B transcription factor is overexpressed in human glioma tissues and that the level of its expression correlates directly with glioma grade. However, whether FoxM1B plays a role in the early development of glioma (i.e., in transformation) is unknown. In this study, we found that the FoxM1B molecule causes cellular transformation and tumor formation in normal human astrocytes (NHA) immortalized by p53 and pRB inhibition. Moreover, brain tumors that arose from intracranial injection of FoxM1B-expressing immortalized NHAs displayed glioblastoma multiforme (GBM) phenotypes, suggesting that FoxM1B overexpression in immortalized NHAs not only transforms the cells but also leads to GBM formation. Mechanistically, our results showed that overexpression of FoxM1B upregulated NEDD4-1, an E3 ligase that mediates the degradation and downregulation of phosphatase and tensin homologue (PTEN) in multiple cell lines. Decreased PTEN in turn resulted in the hyperactivation of Akt, which led to phosphorylation and cytoplasmic retention of FoxO3a. Blocking Akt activation with phosphoinositide 3-kinase/Akt inhibitors inhibited the FoxM1B-induced transformation of immortalized NHAs. Furthermore, overexpression of FoxM1B in immortalized NHAs increased the expression of survivin, cyclin D1, and cyclin E, which are important molecules for tumor growth. Collectively, these results indicate that overexpression of FoxM1B, in cooperation with p53 and pRB inhibition in NHA cells, promotes astrocyte transformation and GBM formation through multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332230      PMCID: PMC2848915          DOI: 10.1158/0008-5472.CAN-09-3909

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Malignant glioma: genetics and biology of a grave matter.

Authors:  E A Maher; F B Furnari; R M Bachoo; D H Rowitch; D N Louis; W K Cavenee; R A DePinho
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

2.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

3.  A genetically tractable model of human glioma formation.

Authors:  J N Rich; C Guo; R E McLendon; D D Bigner; X F Wang; C M Counter
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

4.  Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.

Authors:  Hiroko Asanuma; Toshihiko Torigoe; Kenjiro Kamiguchi; Yoshihiko Hirohashi; Tousei Ohmura; Koichi Hirata; Masaaki Sato; Noriyuki Sato
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

5.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.

Authors:  E C Holland; J Celestino; C Dai; L Schaefer; R E Sawaya; G N Fuller
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

6.  Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.

Authors:  Lene Uhrbom; Marianne Kastemar; Fredrik K Johansson; Bengt Westermark; Eric C Holland
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

7.  Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.

Authors:  Tanya V Kalin; I-Ching Wang; Timothy J Ackerson; Michael L Major; Carol J Detrisac; Vladimir V Kalinichenko; Alexander Lyubimov; Robert H Costa
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

8.  Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo.

Authors:  Melissa M Fraser; Xiaoyan Zhu; Chang-Hyuk Kwon; Erik J Uhlmann; David H Gutmann; Suzanne J Baker
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

9.  FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

Authors:  Mingguang Liu; Bingbing Dai; Shin-Hyuk Kang; Kechen Ban; Feng-Ju Huang; Frederick F Lang; Kenneth D Aldape; Tong-xin Xie; Christopher E Pelloski; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

10.  The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Authors:  Il-Man Kim; Timothy Ackerson; Sneha Ramakrishna; Maria Tretiakova; I-Ching Wang; Tanya V Kalin; Michael L Major; Galina A Gusarova; Helena M Yoder; Robert H Costa; Vladimir V Kalinichenko
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

View more
  38 in total

1.  Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.

Authors:  C Xu; C D Fan; X Wang
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

2.  FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.

Authors:  Chen Huang; Jiawei Du; Keping Xie
Journal:  Biochim Biophys Acta       Date:  2014-01-11

3.  Activation of Akt, not connexin 43 protein ubiquitination, regulates gap junction stability.

Authors:  Clarence A Dunn; Vivian Su; Alan F Lau; Paul D Lampe
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

Review 4.  Emerging insights into the molecular and cellular basis of glioblastoma.

Authors:  Gavin P Dunn; Mikael L Rinne; Jill Wykosky; Giannicola Genovese; Steven N Quayle; Ian F Dunn; Pankaj K Agarwalla; Milan G Chheda; Benito Campos; Alan Wang; Cameron Brennan; Keith L Ligon; Frank Furnari; Webster K Cavenee; Ronald A Depinho; Lynda Chin; William C Hahn
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

5.  Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice.

Authors:  Qiang Li; Zhiliang Jia; Li Wang; Xiangyu Kong; Qi Li; Kun Guo; Dongfeng Tan; Xiangdong Le; Daoyan Wei; Suyun Huang; Lopa Mishra; Keping Xie
Journal:  Gastroenterology       Date:  2011-12-07       Impact factor: 22.682

Review 6.  NEDD4: The founding member of a family of ubiquitin-protein ligases.

Authors:  Natasha Anne Boase; Sharad Kumar
Journal:  Gene       Date:  2014-12-17       Impact factor: 3.688

7.  Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells.

Authors:  Wu Wen; Jingying Li; Longwang Wang; Yifei Xing; Xuechao Li; Hailong Ruan; Xiaoqing Xi; Jianhua Xiong; Renrui Kuang
Journal:  Cell Cycle       Date:  2017-07-26       Impact factor: 4.534

8.  Icariside II induces cell cycle arrest and apoptosis in human glioblastoma cells through suppressing Akt activation and potentiating FOXO3a activity.

Authors:  Kai Quan; Xin Zhang; Kun Fan; Peixi Liu; Qi Yue; Bo Li; Jinfeng Wu; Baojun Liu; Yang Xu; Wei Hua; Wei Zhu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

9.  ΔNp63α represses nuclear translocation of PTEN by inhibition of NEDD4-1 in keratinocytes.

Authors:  Mary K Leonard; Natasha T Hill; Ethan D Grant; Madhavi P Kadakia
Journal:  Arch Dermatol Res       Date:  2013-04-16       Impact factor: 3.017

Review 10.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.